Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1909 1
1919 1
1929 1
1953 2
1956 1
1958 1
1961 2
1962 4
1963 2
1964 2
1965 3
1966 1
1968 2
1969 8
1970 2
1971 3
1972 4
1973 1
1974 6
1975 20
1976 13
1977 10
1978 17
1979 21
1980 17
1981 19
1982 26
1983 24
1984 42
1985 41
1986 44
1987 32
1988 44
1989 52
1990 52
1991 61
1992 56
1993 69
1994 50
1995 64
1996 67
1997 75
1998 78
1999 106
2000 93
2001 106
2002 128
2003 167
2004 186
2005 197
2006 193
2007 215
2008 203
2009 181
2010 177
2011 192
2012 217
2013 232
2014 214
2015 194
2016 211
2017 235
2018 210
2019 204
2020 231
2021 239
2022 252
2023 234
2024 259
2025 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,557 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacotherapy for Treatment-Resistant Depression: Antidepressants and Atypical Antipsychotics.
Vas C, Jain A, Trivedi M, Jha MK, Mathew SJ. Vas C, et al. Psychiatr Clin North Am. 2023 Jun;46(2):261-275. doi: 10.1016/j.psc.2023.02.012. Epub 2023 Mar 25. Psychiatr Clin North Am. 2023. PMID: 37149344 Review.
Treatment-resistant depression (TRD) affects one in three patients with major depressive disorder and is associated with increased risk of all-cause mortality. ...However, rates of remission with antidepressants in TRD are suboptimal. Atypical antipsyc …
Treatment-resistant depression (TRD) affects one in three patients with major depressive disorder and is associated wit …
Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis.
Nuñez NA, Joseph B, Pahwa M, Kumar R, Resendez MG, Prokop LJ, Veldic M, Seshadri A, Biernacka JM, Frye MA, Wang Z, Singh B. Nuñez NA, et al. J Affect Disord. 2022 Apr 1;302:385-400. doi: 10.1016/j.jad.2021.12.134. Epub 2022 Jan 2. J Affect Disord. 2022. PMID: 34986373 Free PMC article. Review.
Nineteen agents were included: stimulants, atypical antipsychotics, thyroid hormones, antidepressants, and mood stabilizers. Data for response/remission and all-cause discontinuation rates were analyzed. ...CONCLUSIONS: This NMA suggests a superiority of the regulatory app …
Nineteen agents were included: stimulants, atypical antipsychotics, thyroid hormones, antidepressants, and mood stabilizers. Data for …
Atypical depression.
Silberman EK, Sullivan JL. Silberman EK, et al. Psychiatr Clin North Am. 1984 Sep;7(3):535-47. Psychiatr Clin North Am. 1984. PMID: 6384959 Review.
Atypical depressions are those characterized by high levels of phobic anxiety or by reversed vegetative symptoms such as hypersomnia and hyperphagia. ...The comparative roles of monoamine oxidase inhibitors, heterocyclic antidepressants, and other biologic treatment …
Atypical depressions are those characterized by high levels of phobic anxiety or by reversed vegetative symptoms such as hyper …
Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
Juruena MF, Bocharova M, Agustini B, Young AH. Juruena MF, et al. J Affect Disord. 2018 Jun;233:45-67. doi: 10.1016/j.jad.2017.09.052. Epub 2017 Oct 6. J Affect Disord. 2018. PMID: 29150144 Review.
The following search items were used: "hypothalamic-pituitary-adrenal" OR "HPA" OR "cortisol" OR "corticotropin releasing hormone" OR "corticotropin releasing factor" OR "glucocorticoid*" OR "adrenocorticotropic hormone" OR "ACTH" AND "atypical depression" OR "non- …
The following search items were used: "hypothalamic-pituitary-adrenal" OR "HPA" OR "cortisol" OR "corticotropin releasing hormone" OR "corti …
Role of Psychedelics in Treatment-Resistant Depression.
Kamal S, Jha MK, Radhakrishnan R. Kamal S, et al. Psychiatr Clin North Am. 2023 Jun;46(2):291-305. doi: 10.1016/j.psc.2023.02.004. Epub 2023 Mar 25. Psychiatr Clin North Am. 2023. PMID: 37149346 Review.
There is increasing interest in exploring the therapeutic potential of psychedelics in treatment-resistant depression (TRD). Classic psychedelics (such as psilocybin, LSD, ayahuasca/DMT), and atypical psychedelics (such as ketamine) have been studied in TRD. ...
There is increasing interest in exploring the therapeutic potential of psychedelics in treatment-resistant depression (TRD). Classic …
Pharmacologic Treatment of Depression.
Kovich H, Kim W, Quaste AM. Kovich H, et al. Am Fam Physician. 2023 Feb;107(2):173-181. Am Fam Physician. 2023. PMID: 36791444
The prevalence of depression and the use of antidepressant medications have risen steadily in the United States over the past three decades. ...Second-generation antidepressants (e.g., selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, s …
The prevalence of depression and the use of antidepressant medications have risen steadily in the United States over the past three d …
Atypical depression: a comprehensive review.
Pae CU, Tharwani H, Marks DM, Masand PS, Patkar AA. Pae CU, et al. CNS Drugs. 2009 Dec;23(12):1023-37. doi: 10.2165/11310990-000000000-00000. CNS Drugs. 2009. PMID: 19958040 Review.
Despite several decades of research, the characteristics distinguishing atypical depression from other depressive subtypes remain ambiguous. Multiple lines of evidence support the designation of atypical depression as a scientifically and clinic …
Despite several decades of research, the characteristics distinguishing atypical depression from other depressive subty …
Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.
Jha MK, Mathew SJ. Jha MK, et al. Am J Psychiatry. 2023 Mar 1;180(3):190-199. doi: 10.1176/appi.ajp.20230025. Am J Psychiatry. 2023. PMID: 36855876 Review.
One in three adults with major depressive disorder (MDD) do not experience clinically significant improvement after multiple sequential courses of antidepressants and have treatment-resistant depression (TRD). ...In the absence of a consensus definition of TR …
One in three adults with major depressive disorder (MDD) do not experience clinically significant improvement after multiple s …
Atypical depression: a valid subtype?
Parker GB, Thase ME. Parker GB, et al. J Clin Psychiatry. 2007 Mar;68(3):e08. doi: 10.4088/jcp.0307e08. J Clin Psychiatry. 2007. PMID: 17388702 Review.
The concept of atypical depression emerged in the 1950s to describe individuals who experienced unusual characteristics of depression and responded better to treatment with monoamine oxidase inhibitors than with tricyclic antidepressants. ...Newer research do …
The concept of atypical depression emerged in the 1950s to describe individuals who experienced unusual characteristics of …
5,557 results